BioLeap's discovery expertise earns big clients; Vivus is out to raise $45M; Pharmasset on the fast track;

@FierceBiotech: Bayer, Algeta shares spike as FDA fast-tracks blockbuster hopeful Alpharadin for prostate cancer. Item | Follow @FierceBiotech

@JohnCFierce: NIH conflict rules for researchers. Researchers have to notify at $5K, but people have to ask to see it. No public site. That's a mistake. | Follow @JohnCFierce

@RyanMFierce: Samsung entering the genomic analysis fray with cloud-based service, free pilot phase from Sept. to Nov. News | Follow @RyanMFierce

@MaureenFierce: "Unabomber Copycat" group threatens nanotechnology researchers. Piece | Follow @MaureenFierce

Xconomy profiles BioLeap, a New Jersey company which helps scientists create molecules which have a good shot at hitting a specified target. And on its roster of clients is the pharma giant GlaxoSmithKline. Report

> Vivus, which is trying to overcome the FDA's concerns about its weight loss drug Qnexa, is raising $45 million from a stock sale. Vivus release

> Pharmasset has landed the FDA's fast track designation for its hepatitis C drug, PSI-938. Release

> San Diego-based Zogenix plans to offer 12 million shares. Release

Pharma News

@FiercePharma: Sanofi could kill two birds with one stone with buyout of India's Universal Medicare. 1. Emerging markets. 2. OTC brands. Story | Follow @FiercePharma

> Docs like pharma dinners--with a few caveats. Article

> Par inks $410M deal for niche generics maker Anchen. News

> Seattle Genetics to test Adcetris in non-Hodgkin's patients. Story

> Sanofi unit gets 40 brands, 750 Indian staffers in buyout. Item

> Spain's new rules shut out off-patent brands. Report

> Takeda eyes Indian M&A, but Cipla, Lupin deny talks. Article

Drug Delivery News

> Unilife boasts 'world's first' safety mechanism in multi-chamber syringe. More

> Alkermes stock upgrade validates drug delivery focus. News

> New nasal delivery method may offer faster, better pain relief. Report

> Drug-delivery company SurModics cuts 9%of workforce after J&J loss. Story

> Echo Therapeutics video shows pain-free skin prep. Details

> Microwaves get bacteria to open sesame. Article

Medical Device News

> Occlutech reports closing of $21.6M financing. More

> Thermo Fisher wraps up Phadia buy. Report

> Aethlon, Sarcoma Oncology Center to study hemopurifier in cancer patients. Article

> GE lays off 81 in Milwaukee. Story

> SurModics cutting 9% of workforce in realignment. News

> Medtronic sees net earnings slide 1% in Q1. Details

And Finally... Researchers at UC San Diego say they've found a cytokine--IL-37--that protects mice from colitis. Report

Suggested Articles

Panelists at the CAR-TCR Summit reflected on gender diversity trends and the challenges women face in the life sciences industry.

Loh joins the computational chemistry specialist after a two-year stint at Kymera Therapeutics.

The $3 billion funding boost includes an additional $350 million for targeted Alzheimer’s research.